Janux Therapeutics stock hits 52-week low at 21.97 USD
NegativeFinancial Markets

Janux Therapeutics has seen its stock price drop to a 52-week low of $21.97, raising concerns among investors about the company's future performance. This decline could reflect broader market trends or specific challenges faced by the company, making it a critical moment for stakeholders to assess their positions and strategies moving forward.
— Curated by the World Pulse Now AI Editorial System